Merck & Co. Inc. closed 36.37% below its 52-week high of $134.63, which the company reached on June 25th.
Merck KGaA said it’s in advanced talks to purchase SpringWorks Therapeutics Inc., sending shares of the US cancer and rare ...
8don MSN
Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback